Meta-analysis of 77 placebo-controlled RCTs (16,416 participants): dual orexin receptor antagonists increased subjective total sleep time by 18.91 min but did not improve sleep quality, and raised somnolence risk (RR 2.91).
Meta-analysisn = 16,416
Stefanou et al. The effect of Dual Orexin Receptor Antagonists on sleep: a systematic review and pairwise meta-analysis